N
THRD

Nuveen’s Third Harmonic Bio THRD Stock Holding History

Nuveen’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-27,963
Closed -$839 – 3297
2025
Q3 		$839 Hold
27,963
– – ﹤0.01% 3254
2025
Q2 		$152K Sell
27,963
-9,283
-25% -$46.3K ﹤0.01% 3210
2025
Q1 		$129K Hold
37,246
– – ﹤0.01% 3189
2024
Q4 		$383K Hold
37,246
– – ﹤0.01% 3071
2024
Q3 		$505K Sell
37,246
-20,220
-35% -$251K ﹤0.01% 3015
2024
Q2 		$747K Buy
57,466
+29,503
+106% +$365K ﹤0.01% 2851
2024
Q1 		$264K Hold
27,963
– – ﹤0.01% 3123
2023
Q4 		$307K Buy
27,963
+1,139
+4% +$9.02K ﹤0.01% 3143
2023
Q3 		$171K Hold
26,824
– – ﹤0.01% 3063
2023
Q2 		$129K Buy
26,824
+9,348
+53% +$44.5K ﹤0.01% 3142
2023
Q1 		$72K Hold
17,476
– – ﹤0.01% 3072
2022
Q4 		$75K Buy
+17,476
New +$292K ﹤0.01% 3124

Other funds holding THRD

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Nuveen's THRD Position: Q4 2025 in Review

Nuveen sold out of Third Harmonic Bio (THRD) in Q4 2025, closing a stake of 27,963 shares — an estimated $839 sold.

Nuveen first reported a position in THRD in Q4 2022 and held it in 12 quarters. The position peaked at $747K in Q2 2024. 4 funds tracked by Wall St. Rank hold THRD as of Q4 2025.

  • Nuveen reported no remaining Third Harmonic Bio position as of Q4 2025 after selling out during the quarter.
  • Nuveen sold 27,963 Third Harmonic Bio shares in Q4 2025, an estimated $839.
  • Nuveen first reported a position in Third Harmonic Bio in Q4 2022 and held it in 12 quarters.
  • Nuveen's Third Harmonic Bio position peaked at $747K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q4 2025.

Based on Nuveen's 13F filing for Q4 2025, filed 12 Feb 2026.